{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:21:28Z","timestamp":1792264888092,"version":"4.4.0"},"reference-count":201,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Toxicology"],"published-print":{"date-parts":[[2025,2,7]]},"DOI":"10.1080\/10408444.2025.2462642","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:22:16Z","timestamp":1744294936000},"page":"248-284","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Mode of action approach supports a lack of carcinogenic potential of six organic UV filters"],"prefix":"10.1080","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5047-0962","authenticated-orcid":false,"given":"Samuel M.","family":"Cohen","sequence":"first","affiliation":[{"name":"Department of Pathology, Immunology, and Microbiology, University of Nebraska Medical Center","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Boobis","sequence":"additional","affiliation":[{"name":"National Heart & Lung Institute, Imperial College London","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jacobson-Kram","sequence":"additional","affiliation":[{"name":"ToxRox Consulting, LLC","place":["Bethesda, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Schoeny","sequence":"additional","affiliation":[{"name":"Rita Schoeny, LLC","place":["Washington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Rosol","sequence":"additional","affiliation":[{"name":"Histology Core Facility and Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University","place":["Athens, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Pathology, Microbiology and Immunology, New York Medical College","place":["Valhalla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert E.","family":"Kaminski","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Michigan State University","place":["East Lansing, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Eichenbaum","sequence":"additional","affiliation":[{"name":"Oaktree Life Sciences Consulting","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Peter","family":"Guengerich","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Vanderbilt University School of Medicine","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Nash","sequence":"additional","affiliation":[{"name":"Procter & Gamble","place":["Mason, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3525"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.009100"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7772"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7782"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2018.04.217"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2015.01.008"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/ftox.2021.748406"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109447"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.635748"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2307\/3454799"},{"key":"e_1_3_3_12_1","unstructured":"Bomhard E Schilde B. 1978. Novantisolsa\u00fcre - Subchronic toxicity study in rats (application by gavage for 3 months). Report No. 7780. Monheim Germany: Bayer AG Institute of Toxicology."},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-7992(82)90097-5"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2017.07.004"},{"issue":"2","key":"e_1_3_3_15_1","first-page":"163","article-title":"Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animals","volume":"54","author":"Bourcier T","year":"2015","unstructured":"Bourcier T, McGovern T, Stavitskaya L, Kruhlak N, Jacobson-Kram D. 2015. Improving prediction of carcinogenicity to reduce, refine, and replace the use of experimental animals. J Am Assoc Lab Anim Sci. 54(2):163\u2013169.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2011.09.002"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-012-0824-2"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.7b03996"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.02.014"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2019.04.001"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-019-02408-7"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.108334"},{"key":"e_1_3_3_23_1","unstructured":"Capen CC Dybing E Rice JM Wilbourn JD editors. 1999. Species Differences in Thyroid Kidney and Urinary Bladder Carcinogenesis. IARC Scientific Publication No. 147. Lyon France: The International Agency for Research on Cancer (IARC)."},{"key":"e_1_3_3_24_1","volume-title":"Maximal usage trials for topically applied active ingredients being considered for inclusion in an over-the -counter monograph: study elements and considerations","author":"CDER FDA","year":"2019","unstructured":"CDER FDA. 2019. Maximal usage trials for topically applied active ingredients being considered for inclusion in an over-the -counter monograph: study elements and considerations. Rockville (MD): FDA."},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(93)90028-x"},{"key":"e_1_3_3_26_1","unstructured":"Chen CT Gan Y Au JL Wientjes MG. 1998. Androgen-dependent and -independent human prostate xenograft tumors as models for drug activity evaluation. Cancer Res. 58(13):2777\u20132783."},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0923-1811(02)00139-1"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310363813"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1039\/c7tx00294g"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1394584"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.01.017"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2204108"},{"issue":"24","key":"e_1_3_3_33_1","first-page":"6493","article-title":"Genetic errors, cell proliferation, and carcinogenesis","volume":"51","author":"Cohen SM","year":"1991","unstructured":"Cohen SM, Ellwein LB. 1991. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51(24):6493\u20136505.","journal-title":"Cancer Res"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(21)00410-9"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2013.06.008"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2013.835784"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-017-2094-7"},{"key":"e_1_3_3_38_1","volume-title":"14-day oral (dietary) range-finding toxicity study in rats","author":"Cosmetic Toiletry and Fragrance Association (CTFA)","year":"1994","unstructured":"Cosmetic Toiletry and Fragrance Association (CTFA). 1994. 14-day oral (dietary) range-finding toxicity study in rats. Mattawan, MI: International Research and Development Corporation (IRDC)."},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114630"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.104481"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408440600975242"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.9.3797"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.0c00461"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/61.1.6"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni0608-569"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-009-0017-3"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2014.931924"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1592"},{"key":"e_1_3_3_49_1","unstructured":"European Chemicals Agency (ECHA). 2010a. 2-ethylhexyl (2E)-3-(4-methoxyphenyl)acrylate. EC No. 629-661-9; CAS No. 83834-59-7. Helsinki Finland: ECHA Chemicals Database. https:\/\/chem.echa.europa.eu\/100.157.824\/overview."},{"key":"e_1_3_3_50_1","unstructured":"European Chemicals Agency (ECHA). 2010b. Octocrilene. EC No. 228-250-8; CAS No. 6197-30-4. Helsinki Finland: ECHA Chemicals Database. https:\/\/chem.echa.europa.eu\/100.025.683\/overview."},{"key":"e_1_3_3_51_1","unstructured":"European Chemicals Agency (ECHA). 2013a. 1-[4-(1 1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)propane-1 3-dione. EC No. 274-581-6; CAS No. 70356-09-1. Helsinki Finland: ECHA Chemicals Database. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/14835."},{"key":"e_1_3_3_52_1","unstructured":"European Chemicals Agency (ECHA). 2013b. 2-ethylhexyl salicylate. EC No. 204-263-4; CAS No. 118-60-5. Helsinki Finland: ECHA Chemicals Database. https:\/\/chem.echa.europa.eu\/100.003.877\/overview."},{"key":"e_1_3_3_53_1","unstructured":"European Chemicals Agency (ECHA). 2013c. 2-phenyl-1H-benzimidazole-5-sulphonic acid. EC No. 248-502-0; CAS No. 27503-81-7. Helsinki Finland: ECHA Chemicals Database. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/5464\/11."},{"key":"e_1_3_3_54_1","unstructured":"European Chemicals Agency (ECHA). 2013d. Homosalate. EC No. 204-260-8; CAS No. 118-56-9. Helsinki Finland: ECHA Chemicals Database. https:\/\/chem.echa.europa.eu\/100.003.874\/overview."},{"key":"e_1_3_3_55_1","volume-title":"Guidance on information requirements and chemical safety assessment","author":"European Chemicals Agency (ECHA)","year":"2015","unstructured":"European Chemicals Agency (ECHA). 2015. Guidance on information requirements and chemical safety assessment. Helsinki, Finland: European Chemicals Agency (ECHA). https:\/\/echa.europa.eu\/guidance-documents\/guidance-on-information-requirements-and-chemical-safety-assessment."},{"key":"e_1_3_3_56_1","volume-title":"1-[4-(1,1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)propane-1,3-dione","author":"European Chemicals Agency (ECHA)","year":"2020","unstructured":"European Chemicals Agency (ECHA). 2020a. 1-[4-(1,1-dimethylethyl)phenyl]-3-(4-methoxyphenyl)propane-1,3-dione. Helsinki, Finland: ECHA Chemicals Database. https:\/\/echa.europa.eu\/nl\/registration-dossier\/-\/registered-dossier\/14835."},{"key":"e_1_3_3_57_1","volume-title":"Octocrylene","author":"European Chemicals Agency (ECHA)","year":"2020","unstructured":"European Chemicals Agency (ECHA). 2020b. Octocrylene. Helsinki, Finland: ECHA Chemicals Database. https:\/\/echa.europa.eu\/registration-dossier\/-\/registered-dossier\/14858\/1."},{"key":"e_1_3_3_58_1","volume-title":"Reports of the scientific committee on cosmetology, 9th Series","author":"European Commission (EC)","year":"2000","unstructured":"European Commission (EC). 2000. Reports of the scientific committee on cosmetology, 9th Series. Spain: Luxembourg: Office for Official Publications of the European Communities."},{"key":"e_1_3_3_59_1","volume-title":"Ban on animal testing","author":"European Commission (EC)","year":"2023","unstructured":"European Commission (EC). 2023. Ban on animal testing. Brussels, Belgium: Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, European Commission (EC); [accessed 2023 Mar 3]."},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2011.04.001"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1998.tb09677.x"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/15287390590895054"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/5.4.437"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61050-2"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8679"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623312444621"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02733-2"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09912-z"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.02.013"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.250308"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001449"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000079"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)15344-5"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfw195"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105160"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(92)90056-q"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0448"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623320972009"},{"key":"e_1_3_3_79_1","volume-title":"Final report: the uterotrophic assay with avobenzone, ensulizole, homosalate, and padimate-O. ILS Project-Study Number: N135-247, Guideline Reference No.: OPPTS 890.1600","author":"Integrated Laboratory Systems (ILS)","year":"2012","unstructured":"Integrated Laboratory Systems (ILS). 2012. Final report: the uterotrophic assay with avobenzone, ensulizole, homosalate, and padimate-O. ILS Project-Study Number: N135-247, Guideline Reference No.: OPPTS 890.1600. Durham, NC: Integrated Laboratory Systems (ILS)."},{"key":"e_1_3_3_80_1","unstructured":"International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 2012. S2(R1) Genotoxicity testing and data interpretation for pharmaceuticals intended for human use. S2(R1). London UK: European Medicines Agency; p. 9 16\u201318."},{"issue":"1","key":"e_1_3_3_81_1","article-title":"M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk","volume":"7","author":"International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)","year":"2017","unstructured":"International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 2017. M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. ICH. M7(R1). London, UK: European Medicines Agency; p. 11\u201314.","journal-title":"ICH"},{"key":"e_1_3_3_82_1","unstructured":"International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 2021. Addendum to the ICH guideline S1B on testing for carcinogenicity of pharmaceuticals. London UK: Eurpean Medicines Agency; p. 2\u20134."},{"key":"e_1_3_3_83_1","volume-title":"Guidance for immunotoxicity risk assessment for chemicals","author":"International Programme on Chemical Safety (IPCS)","year":"2012","unstructured":"International Programme on Chemical Safety (IPCS). 2012. Guidance for immunotoxicity risk assessment for chemicals. Geneva, Switzerland: International Programme on Chemical Safety (IPCS), World Health Organization."},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22725.x"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00866-3"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483x(94)90013-2"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2013.08.006"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(87)90063-x"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfw092"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2005.03.018"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2005.06.026"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22318"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.06.033"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.10.028"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.4.820"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.05.010"},{"key":"e_1_3_3_97_1","unstructured":"Kr\u00f6tlinger F. 2002. Neo Heliopan Typ Hydro \u2013 Uterotrophic assay in immature rats (subcutaneous application by gavage). Report No. PH 31928. Monheim Germany: Bayer AG Institute of Toxicology."},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27765"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.04.018"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquatox.2006.06.016"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.12.018"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2016.06.014"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2018.01.006"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2011.06.026"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfp224"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq234"},{"key":"e_1_3_3_107_1","volume-title":"General approach to calculation of tissue: plasma partition coefficients for physiologically based pharmacokinetic (PBPK) modeling","author":"Lukacova V","year":"2008","unstructured":"Lukacova V, Parrott NJ, Lav\u00e8 T, Fraczkiewicz G, Bolger MB, Woltosz WS. 2008. General approach to calculation of tissue: plasma partition coefficients for physiologically based pharmacokinetic (PBPK) modeling. Atlanta, GA: American Association of Pharmaceutical Scientists (AAPS) National Annual Meeting and Exposition."},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0608390"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(88)90247-3"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2019.04.003"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2022.105289"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2020.12.005"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.125.643"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.4137\/CIN.S7789"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.20747"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.5586"},{"key":"e_1_3_3_117_1","unstructured":"Meschi SDE Chaigneau AM Shields J Delansorne R. 2002. Estrogenic potential of UV filter substances on Ishikawa cell alkaline phosphatase activity. R1185. Report No. R1185. Monaco: Theramex."},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.109-1240632"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2021.08.003"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/66.6.1037"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2005.01.004"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2023.107739"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2005.09.006"},{"key":"e_1_3_3_124_1","unstructured":"National Cancer Institute. 2015. Hormones. [accessed 2022 May 20]. https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/hormones."},{"key":"e_1_3_3_125_1","unstructured":"National Industrial Chemicals Notification and Assessment Scheme (NICNAS). 2017. 2-Propenoic acid 3-(4-methoxyphenyl)- 2-ethylhexyl ester: human health tier II assessment. Sydney Australia: Australian Industrial Chemicals Introduction Scheme."},{"key":"e_1_3_3_126_1","unstructured":"National Institute of Environmental Health Sciences (NIEHS). 2012. The Uterotrophic Assay (OPPTS 890.1600) with oxybenzone octylmethoxycinnamate octylsalate and octocrylene. Study No. N135-231. Durham NC: Integrated Laboratory Systems Inc."},{"key":"e_1_3_3_127_1","volume-title":"Estrogen receptor binding (rat uterine cytosol) final report","author":"National Institute of Environmental Health Sciences (NIEHS)","year":"2013","unstructured":"National Institute of Environmental Health Sciences (NIEHS). 2013. Estrogen receptor binding (rat uterine cytosol) final report. Kalamazoo, MI: CeeTox, Inc."},{"key":"e_1_3_3_128_1","unstructured":"National Toxicology Program (NTP). 2006. NTP technical report on the toxicology and carcinogenesis studies of benzophenone (CAS No. 119-61-9) in F344\/N rats and B6C3F1 mice (feed studies). NTP TR 533. Research Triangle Park NC: National Toxicology Program."},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2013.05.009"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.08.023"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.114093"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1080\/17435390.2016.1206148"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1994.1041"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2232-x"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfad082"},{"key":"e_1_3_3_136_1","unstructured":"Organisation for Economic Co-operation and Development (OECD). 2018. Test No. 408: repeated Dose 90-Day Oral Toxicity Study in Rodents. Paris France: OECD Publishing."},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.11.039"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.39.020188.000431"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfu257"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2017.04.005"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2016.08.014"},{"key":"e_1_3_3_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22248"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2009.07.003"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.20612"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408440591007278"},{"key":"e_1_3_3_146_1","volume-title":"Public comments on draft guidance \u201cOver-the-counter sunscreens: safety and effectiveness data draft guidance for industry\u201d","author":"Public Access to SunScreens (PASS) Coalition","year":"2016","unstructured":"Public Access to SunScreens (PASS) Coalition. 2016. Public comments on draft guidance \u201cOver-the-counter sunscreens: safety and effectiveness data draft guidance for industry\u201d. Silver Spring, MD: PASS Coalition."},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1177\/09603271241254338"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.576969"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09918-7"},{"key":"e_1_3_3_150_1","volume-title":"Handbook of toxicologic pathology","author":"Rosol TJDR","year":"2013","unstructured":"Rosol TJDR, Harvey PW, Sutcliffe C. 2013. The endocrine system. In: Haschek WHRC, Wallig MA, editor. Handbook of toxicologic pathology. 3rd ed. San Diego, CA: Academic Press (Elsevier).","edition":"3"},{"key":"e_1_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.1080\/019262301301418847"},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1205065"},{"key":"e_1_3_3_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.005"},{"key":"e_1_3_3_154_1","first-page":"701","volume-title":"Test for chemical induction of mutation in mammalian cells in culture - The L5178Y TK+\/- mouse lymphoma assay","author":"San RSC.","year":"1990","unstructured":"San RSC. 1990. Test for chemical induction of mutation in mammalian cells in culture - The L5178Y TK+\/- mouse lymphoma assay. Rockville, MD: Microbiological Associates, Inc. Laboratory Study No. T9146; p. 701."},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.201085"},{"key":"e_1_3_3_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2016.03.008"},{"key":"e_1_3_3_157_1","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.01109239"},{"key":"e_1_3_3_158_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-002-0348-4"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi035"},{"key":"e_1_3_3_160_1","unstructured":"Scientific Committee on Consumer Products (SCCP). 2006. Opinion on phenylbenzimidazole sulfonic acid and its salts. Brussels Belgium: European Commission."},{"key":"e_1_3_3_161_1","unstructured":"Scientific Committee on Consumer Products (SCCP). 2007. Opinion on Homosalate. CAS 118-56-9 EINECS 204-260-8. Brussels Belgium: European Commission."},{"key":"e_1_3_3_162_1","unstructured":"Scientific Committee on Consumer Safety (SCCS). 2021. Opinion on Benzophenone-3. Luxembourg. SCCS\/1625\/20."},{"key":"e_1_3_3_163_1","unstructured":"Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP). 2001. Opinion on the Evaluation of Potentially Estrogenic Effects of UV-Filters Adopted by the SCCNFP During the 17th Plenary Meeting of 12 June 2001."},{"key":"e_1_3_3_164_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1222878110"},{"key":"e_1_3_3_165_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.153016"},{"key":"e_1_3_3_166_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0823"},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623311406935"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.080515"},{"key":"e_1_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2000.9025"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040201"},{"key":"e_1_3_3_171_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.3.284-JHA00014-4-1"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713246"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2007.04.014"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq371"},{"key":"e_1_3_3_175_1","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1803011"},{"key":"e_1_3_3_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2006.10.003"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9011"},{"key":"e_1_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260825"},{"key":"e_1_3_3_179_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2019.1573804"},{"key":"#cr-split#-e_1_3_3_180_1.1","unstructured":"U.S. Centers for Disease Control and Prevention (CDC). 2021. Sun safety. Centers for Disease Control and Prevention (CDC)"},{"key":"#cr-split#-e_1_3_3_180_1.2","unstructured":"[accessed 2022 March 8]. https:\/\/www.cdc.gov\/cancer\/skin\/basic_info\/sun-safety.htm."},{"key":"e_1_3_3_181_1","volume-title":"Nonprescription sunscreen drug product-safety and effectiveness data. Guidance for industry","author":"U.S. Food and Drug Administration (FDA)","year":"2016","unstructured":"U.S. Food and Drug Administration (FDA). 2016. Nonprescription sunscreen drug product-safety and effectiveness data. Guidance for industry. Rockville, MD: FDA."},{"key":"e_1_3_3_182_1","volume-title":"Sunscreen: how to help protect your skin from the sun","author":"U.S. Food and Drug Administration (FDA)","year":"2021","unstructured":"U.S. Food and Drug Administration (FDA). 2021. Sunscreen: how to help protect your skin from the sun. United States Food and Drug Administration (FDA), Department of Health and Human Services. Rockville, MD: FDA; [accessed 2022 Mar 8]. https:\/\/www.fda.gov\/drugs\/understanding-over-counter-medicines\/sunscreen-how-help-protect-your-skin-sun."},{"key":"e_1_3_3_183_1","volume-title":"Rulemaking history for OTC sunscreen drug products","author":"U.S. Food and Drug Administration (FDA)","year":"2023","unstructured":"U.S. Food and Drug Administration (FDA). 2023. Rulemaking history for OTC sunscreen drug products. Washington, DC: United States Food and Drug Administration (FDA), Department of Health and Human Services; [updated 8\/30\/2019; accessed 2023 Mar 3]. https:\/\/www.fda.gov\/drugs\/historical-status-otc-rulemakings\/rulemaking-history-otc-sunscreen-drug-products?msclkid=1a6f0f37a7bd11eca365574101cf72c4."},{"key":"e_1_3_3_184_1","unstructured":"U.S. Environmental Protection Agency (EPA). 2024. Endocrine Disruptor Screening Program (EDSP). [accessed 2024 November 1]. https:\/\/www.epa.gov\/endocrine-disruption."},{"key":"e_1_3_3_185_1","doi-asserted-by":"publisher","DOI":"10.1080\/01926230490462138"},{"key":"e_1_3_3_186_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2016.00045"},{"key":"e_1_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2016.1163664"},{"key":"e_1_3_3_188_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.0c00131"},{"key":"e_1_3_3_189_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1178"},{"key":"e_1_3_3_190_1","unstructured":"Weisenburger W. 1991. 91-day subchronic percutaneous toxicity - rabbits. Study No. 392\u2013384."},{"key":"e_1_3_3_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.113684"},{"key":"e_1_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2010.515563"},{"key":"e_1_3_3_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.01.021"},{"key":"e_1_3_3_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.11.002"},{"key":"e_1_3_3_195_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623315576005"},{"key":"e_1_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2016.09.003"},{"key":"e_1_3_3_197_1","first-page":"436","article-title":"Assessment of in\u00a0vitro genotoxicity effect of homosalate in cosmetics","volume":"22","author":"Yazar SG.","year":"2018","unstructured":"Yazar SG. 2018. Assessment of in\u00a0vitro genotoxicity effect of homosalate in cosmetics. Marmara Pharm J. 22:436\u2013442.","journal-title":"Marmara Pharm J"},{"key":"e_1_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12973"},{"key":"e_1_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.2860090602"},{"key":"e_1_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfy036"},{"key":"e_1_3_3_201_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfy133"}],"container-title":["Critical Reviews in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408444.2025.2462642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:03:34Z","timestamp":1745593414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408444.2025.2462642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":201,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,7]]}},"alternative-id":["10.1080\/10408444.2025.2462642"],"URL":"https:\/\/doi.org\/10.1080\/10408444.2025.2462642","relation":{},"ISSN":["1040-8444","1547-6898"],"issn-type":[{"value":"1040-8444","type":"print"},{"value":"1547-6898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}